Selected cases for the study
| Name | Acronym | Application area | Country of origin | Interview contact | |
|---|---|---|---|---|---|
| 1 | Lytics | LYT | Diagnostics, therapy | Sweden | CEO |
| 2 | Byon8 | B8 | Diagnostics, therapy | Sweden | BDO |
| 3 | MMG Artificial Intelligence | MAI | Diagnostics | Spain | CEO |
| 4 | Precure | PRE | Diagnostics | Denmark | CEO |
| 5 | Cerebriu | CER | Diagnostics | Denmark | CEO |
| 6 | Elypta | ELY | Diagnostics | Sweden | CEO |
| 7 | Etsimo | EST | Diagnostics, therapy | Finland | CEO |
| 8 | SYNSIGHT | SYN | Drug discovery | France | CSO |
| 9 | Precisionlife | PCL | Drug discovery | UK | CEO |
| Name | Acronym | Application area | Country of origin | Interview contact | |
|---|---|---|---|---|---|
| 1 | Lytics | LYT | Diagnostics, therapy | Sweden | CEO |
| 2 | Byon8 | B8 | Diagnostics, therapy | Sweden | BDO |
| 3 | MMG Artificial Intelligence | MAI | Diagnostics | Spain | CEO |
| 4 | Precure | PRE | Diagnostics | Denmark | CEO |
| 5 | Cerebriu | CER | Diagnostics | Denmark | CEO |
| 6 | Elypta | ELY | Diagnostics | Sweden | CEO |
| 7 | Etsimo | EST | Diagnostics, therapy | Finland | CEO |
| 8 | SYNSIGHT | SYN | Drug discovery | France | CSO |
| 9 | Precisionlife | PCL | Drug discovery | UK | CEO |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.